Australian Government Faces Opposition Over E-Cigarette Regulation Decision

Regulations by 2FIRSTS.ai
May.27.2024
Australian Government Faces Opposition Over E-Cigarette Regulation Decision
Australia could stand to gain millions in revenue if e-cigarettes are regulated, but the opposition party remains firm on the ban.

According to Australian news outlet YahooNews on May 27, industry experts predict that if Australia were to regulate e-cigarettes, it could bring in millions of dollars in unexpected tax revenue. However, the Labor Party continues to refuse the calls to lift the strict ban on recreational e-cigarettes. Parliament is expected to vote in June on whether to crack down on e-cigarettes, but the government's third anti-e-cigarette bill is facing opposition from the National Party, who are advocating for taxing non-prescription e-cigarette products rather than banning them.

 

Industry models predict that if e-cigarettes are legalized and a consumption tax is implemented, e-cigarettes could potentially generate an additional $600 million in goods and services tax for states such as Victoria and New South Wales within the next four years. National Party MP Barnaby Joyce stated that regulating e-cigarette products like tobacco and alcohol would reduce funds entering the black market, but he also expressed that he does not support regulation of illegal substances like marijuana.

 

According to Joyce, people are benefiting from e-cigarettes, mainly organized crime. If you want to solve this problem, you must strengthen regulation.

 

He mentioned that although he doesn't use e-cigarettes himself, he is aware of the harm they can cause to the body, and even potentially be deadly. However, he also pointed out that traditional tobacco cigarettes also have similar risks, but they are legal. Australian Minister for the Environment, Tanya Plibersek, stated that the government will not change its stance, and said that the nationwide ban is in place to protect the younger generation from the negative health impacts of e-cigarettes.

 

She said, "The only ones hoping to increase e-cigarette sales in Australia are tobacco companies, while their initial consumers are dying from smoking-related health issues." Pruebeixi warned, "We may generate some revenue from taxes, but we may end up spending billions of Australian dollars in the healthcare system to clean up the mess of e-cigarette addiction gripping today's youth.

 

The Labor Party has announced its third set of regulations on vaping, which will ban the domestic manufacturing, advertising, supply, and commercial ownership of non-therapeutic e-cigarettes. Previous regulations, which came into effect in January of this year, have already banned the import of e-cigarettes and increased enforcement activities. The Liberal Party and the Green Party have yet to take a clear stance on the regulations, but Green Party leader Adam Bandt has expressed support for harm reduction rather than prohibition. The Senate is expected to vote on the bill before the end of this session next week or in the next session in June.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26